South Korea
Despite tightening barriers to entry over the years, Europe and the US are still key to global expansion for Korean startups, says Sky Labs CEO Jack Byunghwan Lee.
Seoul National University Hospital researchers have developed an AI model that predicts the response to an anticonvulsant drug.
The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.
It shows potential for early, opportunistic screening for osteoporosis without a separate bone density test, according to Seoul National University Hospital researchers.
The Korean AI company also plans expansion into Vietnam and Hong Kong.
Trained on local medical laws and treatment guidelines, the model scored 96.4 on the 2025 Korean Medical Licensing Examination.
Also, South Korea's Ministry of Health and Welfare has made more patient data available on the My Health Record app.
Also, a Taiwanese consortium is expanding across the Japanese elderly care sector.
Also, Tricog has received fresh investment from Omron to scale its ECG analytics AI.
Early results show 70% accuracy of AI-assisted detection of unexplained male infertility using Asian IVF data.